Rare diseases
Investigational molecules
Locations
Back to Spain3 294 clinical trials in Madrid, Spain across 24 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainStudy on the Safety and Effects of Sparsentan for Children with Proteinuric Kidney Diseases
SpainStudy of RMC-6236 and Pembrolizumab with or without Chemotherapy for Patients with RAS-Mutated Non-Small Cell Lung Cancer
SpainStudy on the Safety and Effectiveness of Fluocinolone Acetonide Implant for Children Aged 6-17 with Recurrent Non-Infectious Uveitis in the Eye's Posterior Segment
SpainStudy of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery
SpainStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
SpainStudy on Clobetasol Propionate and Prednisolone Acetate for Treating Eye Inflammation After Cataract Surgery in Children Aged 0-3 Years
SpainStudy on Esmolol for Heart Issues in Patients with Cirrhosis, Diabetes, or Cardiotoxic Treatment
SpainStudy on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy
SpainStudy of Durvalumab alone and in combination with Tremelimumab in children with advanced solid tumors and blood cancer
SpainStudy on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma
SpainStudy on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis
SpainThe busiest research cities in the country
What the registry says about research in the country
Investigating novel treatments for cutaneous lupus erythematosus and immune thrombocytopenia, with studies evaluating new therapeutic approaches to manage these challenging conditions.
Research focuses on improving treatment outcomes and quality of life for patients with autoimmune disorders.
Clinical trials examining innovative therapies for Type 1 Diabetes in combination with weight management, targeting both glycemic control and obesity-related complications.
Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.
Breakthrough research in multiple sclerosis and acute ischemic stroke, exploring new therapeutic options for both pediatric and adult populations.
Focus on developing targeted treatments to improve neurological outcomes and patient care.
Comprehensive vaccine studies targeting respiratory syncytial virus, influenza, and herpes zoster, with particular attention to vulnerable populations.
Research aims to enhance protection against common and serious infectious diseases.
Innovative studies in mantle cell lymphoma and bladder cancer, exploring combination therapies and targeted treatments to improve patient outcomes.
Focus on developing more effective and personalized cancer treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
